Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Usher Syndrome, Type 2A”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Looking for participantsNCT06627179
What this trial is testing

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

Who this might be right for
Retinitis Pigmentosa (RP)Usher Syndrome Type 2Deaf Blind+4 more
Laboratoires Thea 81
Large-scale testing (Phase 3)Ended earlyNCT05158296
What this trial is testing

Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)

Who this might be right for
Retinitis PigmentosaUsher Syndrome Type 2Deaf Blind+5 more
Laboratoires Thea 7
Not applicableNot Yet RecruitingNCT06545253
What this trial is testing

A New Diagnostic Paradigm for Retinitis Pigmentosa Secondary to USH2A Pathogenic Variants

Who this might be right for
USH2A Variant Retinitis Pigmentosa
IRCCS Ospedale San Raffaele 60
Large-scale testing (Phase 3)Ended earlyNCT05176717
What this trial is testing

Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)

Who this might be right for
Retinitis PigmentosaUsher Syndrome Type 2Deaf Blind+5 more
Laboratoires Thea 5
Testing effectiveness (Phase 2)Study completedNCT03780257
What this trial is testing

Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene

Who this might be right for
Retinitis PigmentosaUsher Syndrome Type 2Deaf Blind+5 more
ProQR Therapeutics 20
Testing effectiveness (Phase 2)Ended earlyNCT05085964
What this trial is testing

An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa

Who this might be right for
Retinitis PigmentosaUsher Syndrome Type 2
Laboratoires Thea 21
Not applicableActive Not RecruitingNCT03146078
What this trial is testing

Rate of Progression in USH2A-related Retinal Degeneration

Who this might be right for
Usher Syndrome, Type 2ARetinitis Pigmentosa 39
Jaeb Center for Health Research 127
Not applicableEnrolling By InvitationNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableUnknownNCT04820244
What this trial is testing

Characterizing Rate of Progression in USHer Syndrome (CRUSH) Study

Who this might be right for
Usher Syndrome, Type 2ARetinitis PigmentosaUSH2A
Radboud University Medical Center 36